Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Feb 21;294(6570):477–480. doi: 10.1136/bmj.294.6570.477

75 deaths in asthmatics prescribed home nebulisers.

M R Sears, H H Rea, J Fenwick, A J Gillies, P E Holst, T V O'Donnell, R P Rothwell
PMCID: PMC1245521  PMID: 3103732

Abstract

The circumstances surrounding the deaths of 75 asthmatic patients who had been prescribed a domiciliary nebuliser driven by an air compressor pump for administration of high dose beta sympathomimetic drugs were investigated as part of the New Zealand national asthma mortality study. Death was judged unavoidable in 19 patients who seemed to have precipitous attacks despite apparently good long term management. Delays in seeking medical help because of overreliance on beta agonist delivered by nebuliser were evident in 12 cases and possible in a further 11, but these represented only 8% of the 271 verified deaths from asthma in New Zealanders aged under 70 during the period. Evidence for direct toxicity of high dose beta agonist was not found. Nevertheless, the absence of serum potassium and theophylline concentrations and of electrocardiographic monitoring in the period immediately preceding death precluded firm conclusions whether arrhythmias might have occurred due to these factors rather than to hypoxia alone. In most patients prescribed domiciliary nebulisers death was associated with deficiencies in long term and short term care similar to those seen in patients without nebulisers. Discretion in prescribing home nebulisers, greater use of other appropriate drugs, including adequate corticosteroids, and careful supervision and instruction of patients taking beta agonist by nebuliser should help to reduce the mortality from asthma.

Full text

PDF
478

Images in this article

480p480-a
on p.480

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cochrane G. M., Prior J. G., Rees P. J. Home nebulisers for airflow limitation. Br Med J (Clin Res Ed) 1985 Jun 1;290(6482):1608–1609. doi: 10.1136/bmj.290.6482.1608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Grant I. W. Asthma in New Zealand. Br Med J (Clin Res Ed) 1983 Jan 29;286(6362):374–377. doi: 10.1136/bmj.286.6362.374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jackson R. T., Beaglehole R., Rea H. H., Sutherland D. C. Mortality from asthma: a new epidemic in New Zealand. Br Med J (Clin Res Ed) 1982 Sep 18;285(6344):771–774. doi: 10.1136/bmj.285.6344.771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Macdonald J. B., Seaton A., Williams D. A. Asthma deaths in Cardiff 1963-74: 90 deaths outside hospital. Br Med J. 1976 Jun 19;1(6024):1493–1495. doi: 10.1136/bmj.1.6024.1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. McGivern D. V., Ward M., Revill S., Sechiari A., Macfarlane J., Davies D. Home nebulizers in severe chronic asthma. Br J Dis Chest. 1984 Oct;78(4):376–382. [PubMed] [Google Scholar]
  6. Ormerod L. P., Stableforth D. E. Asthma mortality in Birmingham 1975-7: 53 deaths. Br Med J. 1980 Mar 8;280(6215):687–690. doi: 10.1136/bmj.280.6215.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Saraux H., Laroche L., Bonnet C., Hubault D. Nécrose rétinienne aiguë bilatérale en deux temps. Rôle de l'infection herpétique? Bull Soc Ophtalmol Fr. 1985 Nov;85(11):1157–1161. [PubMed] [Google Scholar]
  8. Sears M. R., Rea H. H., Beaglehole R., Gillies A. J., Holst P. E., O'Donnell T. V., Rothwell R. P., Sutherland D. C. Asthma mortality in New Zealand: a two year national study. N Z Med J. 1985 Apr 24;98(777):271–275. [PubMed] [Google Scholar]
  9. Sears M. R., Rea H. H., Rothwell R. P., O'Donnell T. V., Holst P. E., Gillies A. J., Beaglehole R. Asthma mortality: comparison between New Zealand and England. Br Med J (Clin Res Ed) 1986 Nov 22;293(6558):1342–1345. doi: 10.1136/bmj.293.6558.1342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sears M. R., Rea H. H., de Boer G., Beaglehole R., Gillies A. J., Holst P. E., O'Donnell T. V., Rothwell R. P. Accuracy of certification of deaths due to asthma. A national study. Am J Epidemiol. 1986 Dec;124(6):1004–1011. doi: 10.1093/oxfordjournals.aje.a114470. [DOI] [PubMed] [Google Scholar]
  11. Stainforth J. N., Lewis R. A., Tattersfield A. E. Dosage and delivery of nebulised beta agonists in hospital. Thorax. 1983 Oct;38(10):751–754. doi: 10.1136/thx.38.10.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Stolley P. D., Schinnar R. Association between asthma mortality and isoproterenol aerosols: a review. Prev Med. 1978 Dec;7(4):519–538. doi: 10.1016/0091-7435(78)90265-7. [DOI] [PubMed] [Google Scholar]
  13. Wilson J. D., Sutherland D. C., Thomas A. C. Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? Lancet. 1981 Jun 6;1(8232):1235–1237. doi: 10.1016/s0140-6736(81)92403-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES